MedTrace Logo

Effects of Sugary Drink Warning Labels on Parent Choices

NCT04259385 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2021-09-20

No results posted yet for this study

Summary

Sugar-sweetened beverages (SSBs) are a significant contributor to adult and childhood obesity. Policies to place health warning labels on sugar-sweetened beverages are being pursued, but there is little empirical data on how such labels influence people. The proposed research will evaluate the impact of different types of sugar-sweetened beverage warning labels relative to standard calorie labels on the purchasing and consumption behaviors of parents and children.

Conditions

  • Food Preferences

Interventions

BEHAVIORAL

Exposure to sugar-sweetened beverage warning labels

Graphic images of the amount of sugar (randomly assigned teaspoons, packets, or cubes) and text warning labels

BEHAVIORAL

Exposure to beverage calorie information

Calories for sugar-sweetened and non-sugar-sweetened beverages

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Drexel University

    collaborator OTHER

  • University of Connecticut

    collaborator OTHER

  • New York University

    collaborator OTHER

  • University of Delaware

    collaborator OTHER

  • University of Pennsylvania

    lead OTHER

Principal Investigators

  • Christina A Roberto, PhD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-11
Primary Completion
2020-03-12
Completion
2020-03-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04259385 on ClinicalTrials.gov